Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-20T06:45:08.441Z Has data issue: false hasContentIssue false
  • English
  • Français

Selective reporting of fluoroquinolone susceptibility as a stewardship measure is of marginal benefit

Published online by Cambridge University Press:  14 April 2020

Geraldine Foo Ting Ting Open the ORCID record for Geraldine Foo Ting Ting [Opens in a new window] ,
Ka Lip Chew Open the ORCID record for Ka Lip Chew [Opens in a new window] ,
Xier Emily Yeo ,
Roland Jureen ,
Dale Fisher Open the ORCID record for Dale Fisher [Opens in a new window]  and
Natasha Bagdasarian Open the ORCID record for Natasha Bagdasarian [Opens in a new window]
Geraldine Foo Ting Ting
Affiliation:
Department of Pharmacy, National University Health System, Singapore
Ka Lip Chew
Affiliation:
Department of Laboratory Medicine, National University Health System, Singapore
Xier Emily Yeo
Affiliation:
Department of Medicine, National University Health System, Singapore
Roland Jureen
Affiliation:
Department of Laboratory Medicine, National University Health System, Singapore
Dale Fisher
Affiliation:
Department of Medicine, National University Health System, Singapore Yong Loo Lin School of Medicine, National University of Singapore, Singapore
Natasha Bagdasarian*
Affiliation:
Department of Medicine, National University Health System, Singapore Yong Loo Lin School of Medicine, National University of Singapore, Singapore
*
Author for correspondence: Natasha Bagdasarian, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

A retrospective time series analysis was conducted to compare inpatient fluoroquinolone use when susceptibilities were masked and after susceptibilities were unmasked. Although inappropriate culture-directed prescriptions increased, overall fluoroquinolone usage decreased. Culture-directed therapy was a small part of fluoroquinolone usage; hence, efforts should target empiric use to reduce overall consumption.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 41 , Issue 6 , June 2020 , pp. 731 - 733
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Paterson, DL.“Collateral damage” from cephalosporin or quinolone antibiotic therapy. Clin Inf Dis 2004;38 supplement 4: S341–S345.CrossRefGoogle Scholar
Al-Tawfiq, JA, Momattin, H, Al-Habboubi, F.Dancer, SJ.Restrictive reporting of selected antimicrobial susceptibilities influences clinical prescribing. J Infect Public Health 2015;8:234–241.CrossRefGoogle ScholarPubMed
Langford, BJ, Seah, J, Chan, A, Downing, M, Johnstone, J, Matukas, LM.Antimicrobial stewardship in the microbiology laboratory: impact of selective susceptibility reporting on ciprofloxacin utilization and susceptibility of gram-negative isolates to ciprofloxacin in a hospital setting. J Clin Microbiol 2016;54:2343–2347.10.1128/JCM.00950-16CrossRefGoogle ScholarPubMed
Pulcini, C, Tebano, G, Mutters, NT, et al.Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey. Int J Antimicrob Agents 2017;49:162–166.CrossRefGoogle ScholarPubMed
FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. US Food & Drug Administration website. https://www.fda.gov/Drugs/DrugSafety/ucm511530.htm Published 2016. Accessed May 23, 2017.Google Scholar
Barlam, TF, Cosgrove, SE, Abbo, LM, et al.Implementing an antibiotic stewardship program: guidelines by the infectious diseases society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 2016;62(10):e51–e77.10.1093/cid/ciw118CrossRefGoogle Scholar
Surveillance atlas of infectious diseases. European Centre for Disease Prevention and Control website. http://atlas.ecdc.europa.eu/public/index.aspx?Instanceprotect%20$%0Delax%20=$GeneralAtlas. Accessed November 28, 2019.Google Scholar
Sanchez, GV, Master, RN, Clark, RB, et al.Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998–2010. Emerg Infect Dis 2013;19:133–136.10.3201/eid1901.120310CrossRefGoogle ScholarPubMed
Elligsen, M, Walker, SA, Pinto, R, et al.Audit and feedback to reduce broad-spectrum antibiotic use among intensive care unit patients: a controlled interrupted time series analysis. Infect Control Hosp Epidemiol 2012;33:354–361.10.1086/664757CrossRefGoogle ScholarPubMed
Lewis, GJ, Fang, X, Gooch, M, et al.Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital’s intensive care and intermediate care units. Infect Control Hosp Epidemiol 2012;33:368–373.CrossRefGoogle Scholar
Supplementary material: File

Ting Ting et al. supplementary material

Table S1

Download Ting Ting et al. supplementary material(File)
File 13.9 KB